SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-15-003194
Filing Date
2015-11-10
Accepted
2015-11-10 16:19:08
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q s102133_10q.htm 10-Q 405999
2 EXHIBIT 10.1 s102133_ex10-1.htm EX-10.1 22597
3 EXHIBIT 10.2 s102133_ex10-2.htm EX-10.2 22422
4 EXHIBIT 31.1 s102133_ex31-1.htm EX-31.1 10575
5 EXHIBIT 31.2 s102133_ex31-2.htm EX-31.2 10248
6 EXHIBIT 32.1 s102133_ex32-1.htm EX-32.1 4346
7 EXHIBIT 32.2 s102133_ex32-2.htm EX-32.2 4347
  Complete submission text file 0001615774-15-003194.txt   3291281

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE enum-20150930.xml EX-101.INS 468457
9 XBRL SCHEMA FILE enum-20150930.xsd EX-101.SCH 35160
10 XBRL CALCULATION FILE enum-20150930_cal.xml EX-101.CAL 48361
11 XBRL DEFINITION FILE enum-20150930_def.xml EX-101.DEF 177589
12 XBRL LABEL FILE enum-20150930_lab.xml EX-101.LAB 314331
13 XBRL PRESENTATION FILE enum-20150930_pre.xml EX-101.PRE 259052
Mailing Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140 (617) 674-1865
Enumeral Biomedical Holdings, Inc. (Filer) CIK: 0001561551 (see all company filings)

IRS No.: 990376434 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55415 | Film No.: 151219174
SIC: 2834 Pharmaceutical Preparations